A non-ionic, water-soluble contrast agent which is used in myelography, arthrography, nephroangiography, arteriography, and other radiological procedures.
A radiopaque medium used for urography, angiography, venography, and myelography. It is highly viscous and binds to plasma proteins.
Triiodo-substituted derivatives of BENZOIC ACID.
A commonly used x-ray contrast medium. As DIATRIZOATE MEGLUMINE and as Diatrizoate sodium, it is used for gastrointestinal studies, angiography, and urography.
X-ray visualization of the spinal cord following injection of contrast medium into the spinal arachnoid space.
A low-osmolar, ionic contrast medium used in various radiographic procedures.
A contrast medium in diagnostic radiology with properties similar to those of diatrizoic acid. It is used primarily as its sodium and meglumine (IOTHALAMATE MEGLUMINE) salts.
Substances used to allow enhanced visualization of tissues.
Immunologically mediated adverse reactions to medicinal substances used legally or illegally.
Works containing information articles on subjects in every field of knowledge, usually arranged in alphabetical order, or a similar work limited to a special field or subject. (From The ALA Glossary of Library and Information Science, 1983)
A nonmetallic element of the halogen group that is represented by the atomic symbol I, atomic number 53, and atomic weight of 126.90. It is a nutritionally essential element, especially important in thyroid hormone synthesis. In solution, it has anti-infective properties and is used topically.
Aquatic invertebrates belonging to the phylum MOLLUSCA or the subphylum CRUSTACEA, and used as food.
An acute hypersensitivity reaction due to exposure to a previously encountered ANTIGEN. The reaction may include rapidly progressing URTICARIA, respiratory distress, vascular collapse, systemic SHOCK, and death.
Poisoning from toxins present in bivalve mollusks that have been ingested. Four distinct types of shellfish poisoning are recognized based on the toxin involved.
Liquid components of living organisms.

Elimination of iomeprol in patients undergoing continuous ambulatory peritoneal dialysis. (1/131)

OBJECTIVE: To examine the elimination of iomeprol, its safety in clinical use, and its peritoneal permeability in continuous ambulatory peritoneal dialysis (CAPD) patients with variable degrees of residual renal function (RRF). DESIGN: A nonrandomized comparison study. SETTING: Hospitalized patients in CAPD unit of Chikuho and University Hospitals. PARTICIPANTS: Fourteen patients treated by CAPD and 6 by hemodialysis (HD). INTERVENTIONS: Total dialysate, blood, and 24-hour urine collections were obtained for 4 consecutive days after the administration of iomeprol. A peritoneal equilibration test was performed just before and after the administration of iomeprol. MEASUREMENTS: Iomeprol (iodine) concentration was measured. Residual renal function was estimated as the mean of renal creatinine and urea clearances. Dialysate-to-plasma ratios (D/P) of creatinine and iomeprol were also determined. RESULTS: In all CAPD patients, plasma iomeprol clearance was markedly slow, with a biological half-life (T1/2) of over 32 hours. However, no patients suffered from any adverse effects, and over 80% of plasma iomeprol was eliminated during the 4-hour HD. The plasma iomeprol elimination rate was significantly higher from 4 hours after the iomeprol administration in CAPD patients with RRF [mean estimated creatinine clearance (CCr) 3.8 mL/min, n = 7] compared to the remaining patients (mean estimated CCr 0.6 mL/min, n = 7); however, T1/2 in patients with RRF was over 24 hours. D/P creatinine was significantly correlated with D/P iomeprol, and peritoneal iomeprol permeability may depend on an individual's peritoneal solute transport properties. CONCLUSIONS: A prolonged elimination rate of iomeprol was documented in our CAPD patients both with and without RRF. A HD procedure or intensive peritoneal dialysis just after the use of iomeprol may be advisable to promptly remove circulating iomeprol.  (+info)

Abdominal aortic aneurysm measurements for endovascular repair: intra- and interobserver variability of CT measurements. (2/131)

OBJECTIVES: to evaluate the intra- and interobserver variability in measurements of the aorta and iliac arteries in patients with abdominal aortic aneurysms (AAAs) considered for endovascular repair using computed tomography angiography (CTA). METHODS: the diameter of the neck, aneurysm, right and left iliac artery were measured by 5 observers in 10 consecutive patients. Measurements were performed on hard copy using a ruler and on a workstation using an electronic caliper. RESULTS: the intraobserver variability showed a decrease going from hard copy to workstation in the standard deviation of the differences of the paired observations for the neck from 3.54 mm to 1.18 mm; for the aorta from 4.16 to 1.72 mm; for the right iliac from 1.87 to 1.01 mm; for the left iliac from 2.07 to 0.87 mm. The interobserver variability showed a similar decrease for the neck in all ten pairs of observers; for the aorta in two, for the right iliac and left iliac in five. However, the difference between observers regularly exceeded 2 mm. CONCLUSION: the use of a workstation and electronic calipers results in lower intra- and interobserver variability. However, the results still show a clinically relevant difference between the observers. Therefore, it is necessary to develop an automatic observer-independent measurement technique.  (+info)

The risk of contrast media-induced ventricular fibrillation is low in canine coronary arteriography with ioxilan. (3/131)

Previous studies have proposed that sodium supplement to nonionic contrast media (CM) can decrease the risk of ventricular fibrillation (VF). This study was designed to compare the occurence of VF induced by ioxilan (containing 9 mmol/LNa+) with other nonionic CMs. After wedging a catheter in the right coronary artery, test solutions including ioxilan, ioversol, iomeprol, and iopromide were infused for 30 sec at the rate of 0.4 ml/sec or until VF occurred. Then, incidence of VF, contact time (i.e. the time required to produce VF), and QTc were measured. Also, the CMs other than ioxilan were investigated at sodium levels adjusted to 9 and 20 mmol/L Na+. The incidence of VF with ioxilan (0%) was the lowest of all. In the other CMs, the incidence decreased in accordance with increase of sodium. Iomeprol and iopromide showed significant reduction of VF incidence at the sodium level of 20 mmol/L. The higher sodium supplements also prolonged the contact times. The increase of QTc was the greatest in ioxilan. Ioxilan has the least arrythmogenic property among the current low-osmolality nonionic CMs. This property might be attributable to an optimal sodium concentration of 9 mmol/L in the CM.  (+info)

Descending aorta wall volume and coronary artery disease: a comparative study using enhanced computed tomography of the chest and coronary angiography. (4/131)

The study examined the association between aortic wall volume (AWV) detected by enhanced computed tomography and coronary artery atherosclerosis observed on angiography. In 180 cases, AWV was measured as the total wall volume of a 7-cm portion of the descending thoracic aorta distal from the tracheal bifurcation. Coronary artery atherosclerosis was angiographically quantified by both Gensini score, in terms of the severity of coronary artery stenosis, and Extent score, in terms of the severity of coronary artery involvement. Mean AWV values between the patients with significant coronary artery stenosis and those without significant stenosis were 9.83+/-4.04 cm3 and 8.09+/-2.39 cm3, respectively (p<0.001). AWV was a significantly independent variable for significant coronary artery disease (p=0.0097) and an Extent score > or = 60 (p=0.0092). Calcification of AWV, however, was not associated with coronary atherosclerosis. The quantification of aortic atherosclerosis was useful for diagnosing coronary artery disease.  (+info)

Proximal tubule cell response to radiographic contrast media. (5/131)

Renal dysfunction associated with contrast media (CM) administration is generally attributed to reduced renal blood flow. Studies, however, also suggest direct tubular effects of CM, whose mechanisms remain unclear. This study was conducted to assess the chemotoxic effects of iopamidol, a prototypic CM, on a porcine proximal tubule (PT) cell line, LLC-PK(1) cells. Results indicate that iopamidol did not affect cell viability (determined by trypan blue exclusion and fluorescein staining), but did reduce cell proliferation. Moreover, iopamidol altered mitochondrial function, as determined by 3-(4, 5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) reduction and mitochondrial membrane potential. Decreased MTT reduction was evident with all CM tested, and its rapid recovery after CM removal suggests that inhibition of mitochondrial function is reversible. Injury to PT cells by iopamidol is supported by the fact that CM increase extracellular adenosine, an indicator of cellular stress. This study provides greater insight into the mechanism underlying the nephrotoxicity induced by contrast in patients and explains the reversibility of this toxicity.  (+info)

Postinfarctional remodeling: increased dye intensity in the myocardial risk area after angioplasty of infarct-related coronary artery is associated with reduction of ventricular volumes. (6/131)

OBJECTIVES: We sought to evaluate if angiographic dye videointensity of the risk area during percutaneous transluminal coronary angioplasty (PTCA) of the infarct-related artery (IRA) relates to remodeling. BACKGROUND: Poor reflow after myocardial infarction (MI) predicts worse ventricular remodeling. METHODS: Fifty-three patients with a first anterior MI and isolated disease of the left anterior descending (LAD), who underwent "primary" (n = 14), "rescue" (n = 7) or "late" (after 10 +/- 4 days, n = 32) PTCA, were retrospectively selected. In 10 patients prospectively collected, we assessed Doppler flow velocities and Doppler flow reserve (DFR), relating them to the videointensity technique. Coronary stenosis and TIMI flow were determined, and echocardiographic volumes (end-diastolic and end-systolic volume indexes) and regional asynergy were computed before hospital discharge (baseline) and at six months. Assuming higher peak videointensity reflects greater myocardial blood volume, a 1- to 5-point (poor-optimal) perfusion scale was devised. RESULTS: The correlation of Doppler peak velocity and DFR with videointensity was significant (r = 0.58, p = 0.007 and r = 0.71, p < 0.001, respectively). Patients were subdivided into group A (increased videointensity post-PTCA > or = 1.5 points, n = 29) and group B (unchanged videointensity, n = 24). Analysis of variance showed a time-group interaction for end-diastolic volume index (-4.6 +/- 23% vs. +22 +/- 22%, p = 0.003) and end-systolic volume index (-3.05 +/- 11.1% vs. +4.1 +/- 12.5%, p = 0.027). There was no interaction for changes in LAD stenosis (p = 0.39) and TIMI flow after PTCA (p = 0.27), or regional asynergy at six months (p = 0.31). CONCLUSIONS: Angiographic dye videointensity in the risk area correlates with Doppler peak velocity and DFR, and its increase after PTCA of IRA has a limiting effect on ventricular volumes, independent of coronary stenosis resolution, changes in Thrombolysis In Myocardial Infarction (TIMI) flow or extent of regional asynergy.  (+info)

Effects of nonionic contrast media on platelet aggregation: assessment by particle counting with laser-light scattering. (7/131)

Intravascular radiographic contrast media used in angiography, particularly nonionic contrast media, may cause activation of platelets. This study was designed to determine which properties of nonionic contrast media were potentially responsible for this action. Platelet aggregation after adenosine diphosphate stimulation was studied in the platelet rich plasma obtained from 37 patients who underwent left ventriculography using the highly sensitive method of particle counting with laser-light scattering. Platelet activation by contrast media was studied in the platelet rich plasma from healthy volunteers using flow cytometric analysis to detect platelet degranulation as P-selectin expression. There was a significant decrease in platelet aggregation in patients injected with ioxilan or iomeprol compared with patients injected with iohexol. There was a significant increase in P-selectin expression with the three groups of contrast media compared to control. The platelet activation with ioxilan or iomeprol was significantly less compared to the activation with iohexol. The comparison showed that previous generalization regarding platelet activation by nonionic contrast media might not be valid. It is presumed that the higher osmolality of iohexol may contribute to the increase in platelet aggregation and activation.  (+info)

Assessment of Fallopian tube patency by HyCoSy: comparison of a positive contrast agent with saline solution. (8/131)

OBJECTIVE: To compare the efficiency of air-filled albumin microspheres (Infoson) with saline solution in determining Fallopian tube patency during hysterosalpingo contrast sonography (HyCoSy). METHODS: This was a prospective randomized multicenter study with a sequential design. Over a 10-month period, 23 patients (mean age, 33 years) referred for infertility were examined by HyCoSy (saline or Infoson) before conventional hysterosalpingography (Iopamiron 370), performed during the same session. Contrast agents were administered through a 5-F Ackrad balloon catheter inserted transcervically into the uterine cavity. HyCoSy was performed with a 7-MHz transvaginal probe using both B-mode and color Doppler, and tubal patency was demonstrated by the appearance of contrast agent in the peritoneal cavity near the ovaries. Data were registered for each patient during the examination and the results were monitored by sequential analysis. RESULTS: Mean volumes of contrast injections were 35.3 mL of saline, 14.4 mL of Infoson, and 13.8 mL of Iopamiron 370. Infoson-enhanced HyCoSy provided a significantly larger (P = 0.006) number of correct diagnoses (20/22 Fallopian tubes) than did saline HyCoSy (12/24 Fallopian tubes), and the same number as that achieved by hysterosalpingography. CONCLUSION: A positive ultrasound contrast agent appears to be more efficient than saline solution at determining Fallopian tube patency in infertile women by means of HyCoSy, and as efficient as an iodinated contrast agent in the same population explored by HSG. HyCoSy could be used to screen infertile women, thereby avoiding the use of iodinated contrast medium and exposure to ionizing radiation during conventional HSG in patients with patent Fallopian tubes.  (+info)

Iopamidol is a non-ionic, low-osmolar contrast media (LOCM) used in diagnostic imaging procedures such as X-rays, CT scans, and angiography. It is a type of radiocontrast agent that contains iodine atoms, which absorb X-rays and make the internal structures of the body visible on X-ray images. Iopamidol has a low osmolarity, which means it has fewer particles per unit volume compared to high-osmolar contrast media (HOCM). This makes it safer and more comfortable for patients as it reduces the risk of adverse reactions such as pain, vasodilation, and kidney damage. Iopamidol is elimated from the body primarily through the kidneys and excreted in the urine.

Iothalamate Meglumine is not a medical condition, but rather a diagnostic contrast agent used in various imaging studies such as computed tomography (CT) scans and magnetic resonance imaging (MRI) exams. Iothalamate Meglumine is a type of radiocontrast medium that contains iodine atoms which help to enhance the visibility of internal structures during these imaging tests.

The medical definition of Iothalamate Meglumine is:

A radiocontrast agent used in diagnostic imaging, specifically in CT scans and MR urography exams. It contains iodine atoms that help to improve the contrast and visibility of internal structures such as the urinary tract. Iothalamate Meglumine is typically administered intravenously or instilled directly into the bladder.

It's important to note that while Iothalamate Meglumine is generally considered safe, it can cause allergic reactions or kidney damage in some individuals, particularly those with pre-existing kidney disease or diabetes. Therefore, it's essential to inform your healthcare provider of any medical conditions or allergies before undergoing an imaging exam that involves the use of this contrast agent.

Triiodobenzoic acids are a group of organic compounds that contain a benzene ring substituted with three iodine atoms and a carboxyl group. They have the general formula C6H3I3CO2H. These compounds do not have a specific medical definition, but they may be used in medical or pharmaceutical applications due to their chemical properties. For instance, some triiodobenzoic acids can act as radioactive tracers in medical imaging or as precursors in the synthesis of certain drugs. However, direct exposure to these compounds should be avoided as they can be harmful if swallowed, inhaled, or absorbed through the skin.

Diatrizoate is a type of contrast medium that is used during X-ray examinations, such as CT scans and urography, to help improve the visibility of internal body structures. It is a type of iodinated compound, which means it contains iodine atoms. Diatrizoate works by blocking the absorption of X-rays, causing the areas where it is injected or introduced to appear white on X-ray images. This can help doctors to diagnose a variety of medical conditions, including problems with the urinary system and digestive tract.

Like all medications and contrast agents, diatrizoate can have side effects, including allergic reactions, kidney damage, and thyroid problems. It is important for patients to discuss any potential risks and benefits of using this agent with their healthcare provider before undergoing an X-ray examination.

Myelography is a medical imaging technique used to examine the spinal cord and surrounding structures, such as the spinal nerves, intervertebral discs, and the spinal column. This procedure involves the injection of a contrast dye into the subarachnoid space, which is the area surrounding the spinal cord filled with cerebrospinal fluid (CSF). The dye outlines the spinal structures, making them visible on X-ray or CT scan images.

The primary purpose of myelography is to diagnose various spinal conditions, including herniated discs, spinal stenosis, tumors, infection, and traumatic injuries. It can help identify any compression or irritation of the spinal cord or nerves that may be causing pain, numbness, weakness, or other neurological symptoms.

The procedure typically requires the patient to lie flat on their stomach or side while the radiologist inserts a thin needle into the subarachnoid space, usually at the lower lumbar level. Once the contrast dye is injected, the patient will be repositioned for various X-ray views or undergo a CT scan to capture detailed images of the spine. After the procedure, patients may experience headaches, nausea, or discomfort at the injection site, but these symptoms usually resolve within a few days.

Ioxaglic acid is not a medical term or a substance used in medicine. It seems that there might be some confusion with the term "iohexol," which is a type of radiocontrast agent containing ioxaglate meglumine, used in medical imaging procedures such as CT scans to improve visualization of internal structures and tissues.

Iohexol is a non-ionic, low-osmolar contrast medium that is less likely to cause adverse reactions compared to high-osmolar contrast media. It works by increasing the X-ray absorption of the area being imaged, making it easier for radiologists to interpret the images and make accurate diagnoses.

Therefore, if you meant "iohexol" instead of "ioxaglic acid," then here is the definition:

Iohexol (trade name Omnipaque) is a radiocontrast agent used in medical imaging procedures such as CT scans to improve visualization of internal structures and tissues. It is a non-ionic, low-osmolar contrast medium that reduces the risk of adverse reactions compared to high-osmolar contrast media. Iohexol works by increasing X-ray absorption in the area being imaged, making it easier for radiologists to interpret the images and make accurate diagnoses.

I'm sorry for any confusion, but "Iothalamic Acid" doesn't appear to be a recognized term in medical or physiological literature. It's possible there may be a spelling error or it could be a highly specialized or obscure term used only in specific research contexts.

If you meant "Iothalamate," that is a compound used as a contrast agent in medical imaging, specifically in radiology for procedures like intravenous pyelograms (IVPs) and computed tomography (CT) scans. Iothalamate is not typically referred to as an acid, though.

Please double-check the term you're looking for, and if there's any chance you meant "Iothalamate," let me know so I can provide a more accurate response!

Contrast media are substances that are administered to a patient in order to improve the visibility of internal body structures or processes in medical imaging techniques such as X-rays, CT scans, MRI scans, and ultrasounds. These media can be introduced into the body through various routes, including oral, rectal, or intravenous administration.

Contrast media work by altering the appearance of bodily structures in imaging studies. For example, when a patient undergoes an X-ray examination, contrast media can be used to highlight specific organs, tissues, or blood vessels, making them more visible on the resulting images. In CT and MRI scans, contrast media can help to enhance the differences between normal and abnormal tissues, allowing for more accurate diagnosis and treatment planning.

There are several types of contrast media available, each with its own specific properties and uses. Some common examples include barium sulfate, which is used as a contrast medium in X-ray studies of the gastrointestinal tract, and iodinated contrast media, which are commonly used in CT scans to highlight blood vessels and other structures.

While contrast media are generally considered safe, they can sometimes cause adverse reactions, ranging from mild symptoms such as nausea or hives to more serious complications such as anaphylaxis or kidney damage. As a result, it is important for healthcare providers to carefully evaluate each patient's medical history and individual risk factors before administering contrast media.

Drug hypersensitivity is an abnormal immune response to a medication or its metabolites. It is a type of adverse drug reaction that occurs in susceptible individuals, characterized by the activation of the immune system leading to inflammation and tissue damage. This reaction can range from mild symptoms such as skin rashes, hives, and itching to more severe reactions like anaphylaxis, which can be life-threatening.

Drug hypersensitivity reactions can be classified into two main types: immediate (or IgE-mediated) and delayed (or non-IgE-mediated). Immediate reactions occur within minutes to a few hours after taking the medication and are mediated by the release of histamine and other inflammatory mediators from mast cells and basophils. Delayed reactions, on the other hand, can take several days to develop and are caused by T-cell activation and subsequent cytokine release.

Common drugs that can cause hypersensitivity reactions include antibiotics (such as penicillins and sulfonamides), nonsteroidal anti-inflammatory drugs (NSAIDs), monoclonal antibodies, and chemotherapeutic agents. It is important to note that previous exposure to a medication does not always guarantee the development of hypersensitivity reactions, as they can also occur after the first administration in some cases.

The diagnosis of drug hypersensitivity involves a thorough medical history, physical examination, and sometimes skin or laboratory tests. Treatment typically includes avoiding the offending medication and managing symptoms with antihistamines, corticosteroids, or other medications as needed. In severe cases, emergency medical care may be required to treat anaphylaxis or other life-threatening reactions.

An encyclopedia is a comprehensive reference work containing articles on various topics, usually arranged in alphabetical order. In the context of medicine, a medical encyclopedia is a collection of articles that provide information about a wide range of medical topics, including diseases and conditions, treatments, tests, procedures, and anatomy and physiology. Medical encyclopedias may be published in print or electronic formats and are often used as a starting point for researching medical topics. They can provide reliable and accurate information on medical subjects, making them useful resources for healthcare professionals, students, and patients alike. Some well-known examples of medical encyclopedias include the Merck Manual and the Stedman's Medical Dictionary.

Iodine is an essential trace element that is necessary for the production of thyroid hormones in the body. These hormones play crucial roles in various bodily functions, including growth and development, metabolism, and brain development during pregnancy and infancy. Iodine can be found in various foods such as seaweed, dairy products, and iodized salt. In a medical context, iodine is also used as an antiseptic to disinfect surfaces, wounds, and skin infections due to its ability to kill bacteria, viruses, and fungi.

Medical definitions typically focus on the potential risks or reactions related to a substance, rather than providing a general definition. In the context of medicine, shellfish are often defined by the allergens they contain, rather than as a culinary category.

According to the American College of Allergy, Asthma & Immunology (ACAAI), shellfish are divided into two categories: crustaceans and mollusks. Crustaceans include shrimp, crab, lobster, and crayfish. Mollusks include clams, mussels, oysters, scallops, octopus, and squid.

Shellfish allergies are one of the most common food allergies, and they can cause severe reactions, including anaphylaxis. Therefore, in a medical context, it's essential to be specific about which types of shellfish may pose a risk to an individual.

Anaphylaxis is a severe, life-threatening systemic allergic reaction that occurs suddenly after exposure to an allergen (a substance that triggers an allergic reaction) to which the person has previously been sensitized. The symptoms of anaphylaxis include rapid onset of symptoms such as itching, hives, swelling of the throat and tongue, difficulty breathing, wheezing, cough, chest tightness, rapid heartbeat, hypotension (low blood pressure), shock, and in severe cases, loss of consciousness and death. Anaphylaxis is a medical emergency that requires immediate treatment with epinephrine (adrenaline) and other supportive measures to stabilize the patient's condition.

Shellfish poisoning refers to illnesses caused by the consumption of shellfish contaminated with harmful toxins produced by certain types of microscopic algae. These toxins can accumulate in various species of shellfish, including mussels, clams, oysters, and scallops, and can cause a range of symptoms depending on the specific type of toxin involved.

There are several types of shellfish poisoning, each caused by different groups of algal toxins:

1. Paralytic Shellfish Poisoning (PSP): Caused by saxitoxins produced by dinoflagellates such as Alexandrium spp., Gymnodinium catenatum, and Pyrodinium bahamense. Symptoms include tingling or numbness of the lips, tongue, and fingers, followed by weakness, difficulty swallowing, and potentially paralysis and respiratory failure in severe cases.
2. Amnesic Shellfish Poisoning (ASP): Caused by domoic acid produced by diatoms such as Pseudo-nitzschia spp. Symptoms include gastrointestinal distress, memory loss, disorientation, seizures, and in severe cases, coma or death.
3. Diarrheal Shellfish Poisoning (DSP): Caused by okadaic acid and its derivatives produced by dinoflagellates such as Dinophysis spp. and Prorocentrum spp. Symptoms include diarrhea, nausea, vomiting, abdominal cramps, and occasionally chills and fever.
4. Neurotoxic Shellfish Poisoning (NSP): Caused by brevetoxins produced by dinoflagellates such as Karenia brevis. Symptoms include reversible neurological symptoms like tingling or numbness of the lips, tongue, and fingers, as well as respiratory irritation, coughing, and chest tightness in severe cases.
5. Azaspiracid Shellfish Poisoning (AZP): Caused by azaspiracids produced by dinoflagellates such as Azadinium spp. Symptoms include gastrointestinal distress, nausea, vomiting, diarrhea, and abdominal pain.

It is essential to note that shellfish contaminated with these toxins may not show visible signs of spoilage or illness-causing bacteria; therefore, it is crucial to avoid consuming them during harmful algal blooms (HABs) or red tide events. Public health authorities often issue warnings and close shellfish beds when HABs are detected in the water. Always check local advisories before consuming shellfish, especially if you have harvested them yourself. Cooking does not destroy these toxins, so they remain harmful even after cooking.

Body fluids refer to the various liquids that can be found within and circulating throughout the human body. These fluids include, but are not limited to:

1. Blood: A fluid that carries oxygen, nutrients, hormones, and waste products throughout the body via the cardiovascular system. It is composed of red and white blood cells suspended in plasma.
2. Lymph: A clear-to-white fluid that circulates through the lymphatic system, helping to remove waste products, bacteria, and damaged cells from tissues while also playing a crucial role in the immune system.
3. Interstitial fluid: Also known as tissue fluid or extracellular fluid, it is the fluid that surrounds the cells in the body's tissues, allowing for nutrient exchange and waste removal between cells and blood vessels.
4. Cerebrospinal fluid (CSF): A clear, colorless fluid that circulates around the brain and spinal cord, providing protection, cushioning, and nutrients to these delicate structures while also removing waste products.
5. Pleural fluid: A small amount of lubricating fluid found in the pleural space between the lungs and the chest wall, allowing for smooth movement during respiration.
6. Pericardial fluid: A small amount of lubricating fluid found within the pericardial sac surrounding the heart, reducing friction during heart contractions.
7. Synovial fluid: A viscous, lubricating fluid found in joint spaces, allowing for smooth movement and protecting the articular cartilage from wear and tear.
8. Urine: A waste product produced by the kidneys, consisting of water, urea, creatinine, and various ions, which is excreted through the urinary system.
9. Gastrointestinal secretions: Fluids produced by the digestive system, including saliva, gastric juice, bile, pancreatic juice, and intestinal secretions, which aid in digestion, absorption, and elimination of food particles.
10. Reproductive fluids: Secretions from the male (semen) and female (cervical mucus, vaginal lubrication) reproductive systems that facilitate fertilization and reproduction.

"Isovue 300- iopamidol injection, solution Isovue 370- iopamidol injection, solution Isovue 200- iopamidol injection, solution ... "Iopamidol Use During Pregnancy". Drugs.com. 31 March 2020. Retrieved 14 August 2020. "Iopamidol". Drug Information Portal. U.S ... Iopamidol (INN), sold under the brand name Isovue among others, is a nonionic, low-osmolar iodinated contrast agent, developed ... Iopamidol is indicated for angiography throughout the cardiovascular system, including cerebral and peripheral arteriography, ...
In 1981 the company launched Iopamidol in Italy and Germany. In the second half of the 1980s, Bracco Spa became the leading ...
Non-ionic contrast media such as iopamidol and iohexol are used. Needles are inserted through the back into the disc near the ...
... or medium-osmolarity iodinated contrast agents such as iopamidol or iohexol. After intravenous infusion, iobitridol is ...
The molecular formula C17H22I3N3O8 (molar mass: 777.085 g/mol) may refer to: Iomeprol Iopamidol This set index page lists ...
In a second step, hook wires, thread needles, or contrast agent (lipiodol, iopamidol) are introduced into or next to the lesion ...
Ionosol Iontocaine iopamidol (INN) iopanoic acid (INN) iopentol (INN) iophenoic acid (INN) Iopidine ioprocemic acid (INN) ...
Iocarmic acid V08AA09 Methiodal V08AA10 Diodone V08AB01 Metrizamide V08AB02 Iohexol V08AB03 Ioxaglic acid V08AB04 Iopamidol ...
... iopamidol MeSH D02.241.223.100.140.100.375.880.420 - iothalamate meglumine MeSH D02.241.223.100.140.100.375.880.430 - ...
Herbal medications, spider bites, iopamidol (used for radiocontrast), lacquers, mercury, psoralen (combined with ultraviolet A ...
"Isovue 300- iopamidol injection, solution Isovue 370- iopamidol injection, solution Isovue 200- iopamidol injection, solution ... "Iopamidol Use During Pregnancy". Drugs.com. 31 March 2020. Retrieved 14 August 2020. "Iopamidol". Drug Information Portal. U.S ... Iopamidol (INN), sold under the brand name Isovue among others, is a nonionic, low-osmolar iodinated contrast agent, developed ... Iopamidol is indicated for angiography throughout the cardiovascular system, including cerebral and peripheral arteriography, ...
"Iopamidol" is a descriptor in the National Library of Medicines controlled vocabulary thesaurus, MeSH (Medical Subject ... This graph shows the total number of publications written about "Iopamidol" by people in this website by year, and whether " ... Singh S, Rajpal C, Nannapeneni S, Venkatesh S. Iopamidol myelography-induced seizures. MedGenMed. 2005 Apr 11; 7(2):11. ... Below are the most recent publications written about "Iopamidol" by people in Profiles. ...
Iopamidol Injection-Kelun Group
兄弟科技股份有限公司成立于1991年,总部位于浙江省海宁市,经过多年的发展,现已成长为拥有皮化、维生素、香料、原料药四个事业部,多个全资子公司
NGK-C-011 / Iopamidol (iopromide) Iopamidol (iopromide). Injection equiv 300 mg iodine/mL in 50 or 100 ml vial Injection equiv ...
Product Name:API and FDF: Iohexol, Iopamidol, Iodixanol, Ioversol,Iopromide,levofloxacin. CAS No.:66108-95-0,60166-93-0,92339- ... You are here: Home > Products > Active Pharmaceutical Ingredients > API and FDF: Iohexol, Iopamidol, Iodixanol, Ioversol, ... API and FDF: Iohexol, Iopamidol, Iodixanol, Ioversol,Iopromide,levofloxacin Category:Active Pharmaceutical Ingredients. ... Iopamidol, Iodixanol, Ioversol,Iopromide,levofloxacin; CAS No.:66108-95-0,60166-93-0,92339-11-2,87771-40-2,73334-07-3,78649-41- ...
... Iopamidol 76% Injection Vial 500 mL , 6/Case Bracco 00270131698 00270-1316-98 ... Iopamidol 76% Injection Vial 500 mL , 6/Case Bracco 00270131698. Isovue-370 Contrast Media Iopamidol 76% Injection Vial 500 mL ... Iopamidol 76% Injection Vial 500 mL , 6/Case Bracco 00270131698. Isovue-370 Contrast Media ... Iopamidol 76% Injection Vial 500 mL , 6/Case Bracco 00270131698. TERMS & CONDITIONS FOR PURCHASING INJECTABLES & MEDICATIONS : ...
Iopamidol: (Major) Use of medications that lower the seizure threshold should be carefully evaluated when considering ...
Iopamidol: (Contraindicated) Because both intrathecal corticosteroids (i.e., dexamethasone) and intrathecal radiopaque contrast ...
Either metrizamide or iopamidol was used as the contrast agent. Two of the four cats had CT and pathologic evidence of cord ...
After bilateral embolization, iopamidol was injected at the level of aortic trifurcation and revealed no further fluoroscopic ... Helical CT images were obtained before and after administration of iopamidol (370 mg I/mL; 3.0 mL/kg, IV). To maintain ... The total duration of prostate TAE was 70 minutes, duration of general anesthesia was 245 minutes, and amount of iopamidol ... After the guidewire and catheter were advanced into the aorta, small volumes of iopamidol were injected to fluoroscopically map ...
Isovue-200 (Iopamidol). December 14, 2010 Iberet-Folic-500 (Multivitamin With Iron). November 8, 2010 ...
With the presence of NOM, the order with respect to the maximum yield of I-THMs observed during chlorination was iopamidol ,, ... With the presence of NOM, the order with respect to the maximum yield of I-THMs observed during chlorination was iopamidol ,, ... With the exception of iopamidol, I-THM formation was favored at relatively low chlorine doses (≤100 μM) during ICM chlorination ... With the exception of iopamidol, I-THM formation was favored at relatively low chlorine doses (≤100 μM) during ICM chlorination ...
Study Week 7 - Notes flashcards from Sabine Reynoso's class online, or in Brainscape's iPhone or Android app. ✓ Learn faster with spaced repetition.
Contrast Agent Isovue-370 (iopamidol injection 76%) used in international investigation assessing multislice CT for diagnostic ...
Proprietaryiodine contrast, Iopamilon®Injection Syringe (iopamidol, 300/370 mg. Table 1. CT examination protocol. ...
Metrizamide was not entirely nontoxic, and second-generation nonionic agents such as iohexol (Omnipaque) and iopamidol (Isovue ...
... iopamidol, ioversol and meglumine diatrizoate, of which the former three varieties were listed among the best-selling 200 drugs ...
Isovue 300 (Iopamidol) has been tested and is not recommended for use due to the inadequate suspension times. Contrast agents ... Iopamidol), Ultravist 350 (Iopromide). *Other contrast agents have not been tested in conjunction with DC Bead LUMI. ...
... in the degradation of iopamidol: Kinetics, energy requirements and DBPs-related toxicity in sequential disinfection processes. ...
Evaluating iopamidol degradation performance and potential dual-wavelength synergy by UV-LED irradiation and UV-LED/chlorine ...
The first stop for professional medicines advice
Iopamidol イオパミドール Tolvaptan トルバプタン ...
IOPAMIDOL 52855 IOPANOIC ACID 52857 ISOBUTANE 52858 ISOBUTYL PABA 52860 IOPHENDYLATE 52865 IOTHALAMATE 52870 IPECAC 52880 ...
... as the majorcontrast players prepare for the introduction of generic versionsof Braccos iopamidol (SCAN Special Report 5/96). ...
Iopamidol, produced in 1981 as the result of research by the legendary Professor Ernst Felder, proved to be a revolutionary ...
Iopamidol, Iohexol, Irbesartan, Lacosamide, Levetiracetam, Levodopa, Losartan, Nabumetone, Naproxen, Naproxen Sodium, ...
Inopha is supplier of GMP quality Tibolone API, raw material of medicine used in menopausal hormone therapy and in the treatment of postmenopausal osteoporosis and endometriosis. Send us enquiry for Tibolone you have interest to buy Tibolone powder.

No FAQ available that match "iopamidol"

No images available that match "iopamidol"